Craft

BIoEclipse Therapeutics

Total Funding

$7.7 M

BIoEclipse Therapeutics Summary

Company Summary

Overview
BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics to patients with cancer. Its technology safely activates a patient’s own immune cells, pair them with a tumor-killing agent, and together they work to defeat the patient’s cancer and prevent a recurrence.
Type
Private
Status
Active
HQ
South San Francisco, CA, US | view all locations
Website
https://www.bioeclipse.com/
Cybersecurity rating
Sectors

Key People

  • Pamela R. Contag

    Pamela R. Contag, Chief Executive Officer, Director and Co-Founder

    • Benjamin C. Carter

      Benjamin C. Carter, CFO

      • Catherine Sohn

        Catherine Sohn, Chairman, Director

        • Gregory T. Schiffman, Director

          LocationsView all

          2 locations detected

          • South San Francisco, CA HQ

            United States

            329 Oyster Point Blvd 3rd Floor

          • Mountain View, CA

            United States

            319 N Bernardo Ave

          Footer menu